Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 


New findings could aid early diagnosis of common eye disease

New findings could aid early diagnosis of common eye disease in elderly


Researchers at the University of Auckland have discovered that age-related macular degeneration – the most common form of vision loss in the elderly – extends to areas outside the macula, a discovery which could prove critical in helping prevent the onset of the disease.

Molecular cell biologist Dr Monica Acosta led the Health Research Council of New Zealand-funded study, which used both human donor tissues from the New Zealand Eye Bank and animal models to investigate the early stages of age-related macular degeneration (AMD).

Clinically, AMD is diagnosed when yellow protein deposits called drusen are seen in the macula – a small part in the centre of the eye’s retina, about the size of a pinhead, which is responsible for clear and detailed central vision. However, Dr Acosta and her team have found that molecular changes associated with AMD, including the presence of drusen and changes in cell communication, occur outside the macula. Inflammation also occurs in an area just above the retina called the choroid.

“Until now, people have focused on developing interventions to prevent the death of photosensitive cells in the macula. Our findings suggest that the changes in the macula that result in vision loss may actually be due to changes in the choroid, and that visual function should be monitored across the retina,” says Dr Acosta.

To further investigate this finding, Dr Acosta’s group used an animal model of AMD to test alternative treatment options. They found that administering a peptide called connexin 43, which acts on the channels (gap junctions) between cells, significantly reduced inflammation in the choroid and retina. Co-researchers Professors Colin Green and Helen Danesh-Meyer from the university’s Ophthalmology Department have been researching different aspects of this molecule for many years.

“We don’t know if this molecule is interacting with the outer part of the channels or the inner part, or what the mechanism of action is. However, it’s intervening at a critical step of the damaging process to restore retinal function and stop the spread of the disease.”
Dr Acosta says looking at the ways cells communicate with each other could be one of the keys to developing alternative therapies for AMD.

“The disease affects people over 60 for whom genetic and environmental factors, principally as a consequence of light damage, may cause changes to the macular area. We need to find the reasons for this and a cure as it’s devastating for the elderly and their families.”

For this study, the team used human donor tissue from three patients who had advanced AMD. Dr Acosta hopes that by using more human donor tissue, and improving the animal model, they will be able to look for inflammation in other areas not normally targeted, with the aim of stopping the progress of the disease.

“Now that we have identified a molecule with the ability to combat the spread of inflammation, oxidative stress, and cell death, as well as trigger repair mechanisms, we have good prospects for advancing that line of research.”

Dr Acosta says that while their research is in the early stages, it offers exciting possibilities for the treatment of retinal diseases.

“I’m convinced that we have the clues for finding the right therapies and interventions at the protein and cellular level. With the support of my colleagues in optometry and ophthalmology, it’s possible to apply or translate our findings to a clinical environment, and this is something we will look at pursuing in the near future.”


Information: Dr Monica Acosta
Department of Optometry and Vision Science
The University of Auckland
Phone: +64 9 923 6069
Email: m.acosta@auckland.ac.nz


-Ends-

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Scoop Business: RBNZ Starts Talks On Tougher Rules For Property Speculators

The Reserve Bank of New Zealand is stepping up preparations to restrict lending to residential property investors as it watches house prices, particularly in Auckland, continue to rise strongly. More>>

ALSO:

Research: ‘Ageing Well’ Science Challenge Launched

Science and Innovation Minister Steven Joyce today launched the Ageing Well National Science Challenge, confirming initial funding of $14.6 million. More>>

ALSO:

Scoop Business: Govt Resisting Pressure To Pump More Cash Into Solid Energy

Prime Minister John Key says it is “not the government’s preferred option” to make a fresh capital injection into the troubled state-owned coal miner, Solid Energy, but dodged journalists’ questions at his weekly press conference on whether that might prove necessary... More>>

ALSO:

Lagest Ever Privacy Breach Award: NZCU Baywide Accepts “Severe” Censure In Cake Case

NZCU Baywide says that once it was found to have committed a breach of a former staff member’s privacy, it had attempted to resolve the matter... the censure and remedies for its actions taken almost three years ago are “severe” but accepted, and will hopefully draw a line under the matter. More>>

ALSO:

Scoop Business: PayPal Stops Processing Mega Payments; NZX Listing Still On

PayPal has ceased processing payments for Mega, the file storage and encryption firm looking to join the New Zealand stock market via a reverse listing of TRS Investments, amid claims it is not a legitimate cloud storage service. More>>

ALSO:

Housing Policy: Auckland Densification As Popular As Ebola, English Says

Finance Minister Bill English said calls by the Reserve Bank Governor for more densification in Auckland’s housing were “about as popular in parts of Auckland as Ebola” would be. More>>

ALSO:

Get More From Scoop

 
 
Standards New Zealand

Standards New Zealand
 
 
 
 
 
 
 
 
Sci-Tech
Search Scoop  
 
 
Powered by Vodafone
NZ independent news